Compare · DHR vs QSI
DHR vs QSI
Side-by-side comparison of Danaher Corporation (DHR) and Quantum-Si Incorporated (QSI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DHR and QSI operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- DHR is the larger of the two at $144.67B, about 793.3x QSI ($182.4M).
- Over the past year, DHR is down 2.7% and QSI is down 25.2% - DHR leads by 22.5 points.
- DHR has been more active in the news (20 items in the past 4 weeks vs 2 for QSI).
- DHR has more recent analyst coverage (25 ratings vs 4 for QSI).
- Company
- Danaher Corporation
- Quantum-Si Incorporated
- Price
- $203.63-1.09%
- $0.87+4.11%
- Market cap
- $144.67B
- $182.4M
- 1M return
- +1.42%
- +1.11%
- 1Y return
- -2.66%
- -25.18%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 20
- 2
- Recent ratings
- 25
- 4
Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Quantum-Si Incorporated
Quantum-Si incorporated operates first next-generation protein sequencing and genomics platform for healthcare industries. It offers a single molecule detection solution to decode the molecules of life, including sample preparation, single molecule, massively parallel, and protein identification. The company's technology has the applications in proteomics, single cell, transcriptomics, genomics, metabolomics, and drug testing and screening fields. The company is based in Guilford, Connecticut. Quantum-Si incorporated is a subsidiary of 4Catalyzer Corporation.
Latest DHR
- Executive Vice President Riley Christopher Paul was granted 41,072 shares, increasing direct ownership by 201% to 61,472 units (SEC Form 4)
- SEC Form 4 filed by EVP & Chief Financial Officer Gugino Matthew E
- SEC Form 4 filed by SVP-Chief Legal Officer Leiken Jonathan
- SVP, Chief Science Officer Gutierrez-Ramos Jose-Carlos was granted 13,477 shares, increasing direct ownership by 71% to 32,495 units (SEC Form 4)
- SEC Form 4 filed by Executive Vice President Sawyer Montgomery Julie A
- SEC Form 4 filed by VP, Chief Accounting Officer Bouda Christopher
- Executive Vice President Milosevich Gregory M was granted 15,402 shares, increasing direct ownership by 170% to 24,467 units (SEC Form 4)
- Chairman of Exec. Committee Rales Mitchell P was granted 500,000 shares, increasing direct ownership by 939% to 553,228 units (SEC Form 4)
- Chairman Rales Steven M was granted 500,000 shares, increasing direct ownership by 16% to 3,605,808 units (SEC Form 4)
- SEC Form 4 filed by Director Zerhouni Elias A.
Latest QSI
- Quantum-Si to Report Second Quarter 2026 Financial Results on August 13, 2026
- Quantum-Si Incorporated filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- GC & Corp. Secretary Lapointe Christian sold $14,469 worth of shares (15,588 units at $0.93), decreasing direct ownership by 1% to 1,182,429 units (SEC Form 4) to satisfy tax liability
- Chief Financial Officer Keyes Jeffry R. sold $7,642 worth of shares (8,233 units at $0.93), decreasing direct ownership by 0.48% to 1,724,349 units (SEC Form 4) (tax withholding)
- Chief Product Officer Vieceli John S. sold $28,053 worth of shares (30,223 units at $0.93), decreasing direct ownership by 3% to 1,140,434 units (SEC Form 4) (withholding obligation)
- President & CEO Hawkins Jeffrey Alan sold $20,997 worth of shares (22,621 units at $0.93), decreasing direct ownership by 0.61% to 3,669,802 units (SEC Form 4) (for tax liability)
- SEC Form 144 filed by Quantum-Si Incorporated
- SEC Form 144 filed by Quantum-Si Incorporated
- Quantum-Si Incorporated filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)